Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON43451Active, not recruiting
Trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 cohorts), sponsored by Donders Institute for Brain, Cognition and Behaviour. Primary endpoints: Oscillatory power modulation during attentional performance, Diffusion tensor imaging measures and 1 more. Started Sep 2016; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON43451.